Your search for supplemental oxygen returned 60 results

Use of home oxygen is associated with reduced physical function in patients with either COPD or idiopathic pulmonary fibrosis.

Routine use of supplemental oxygen does not reduce one-year all-cause mortality versus ambient air

Researchers find oxygen therapy does not improve quality of life, forestall hospitalization, lengthen lives

The update was based on data from the COV-BARRIER study.

The EUA was issued based on 4 randomized controlled clinical trials that evaluated the efficacy and safety of Actemra in more than 5500 hospitalized patients with COVID-19.

Findings showed that the trial did not meet statistical significance on the primary endpoint.

Authors call for larger clinical trials to further evaluate the efficacy and safety of colchicine as an adjunctive therapy for COVID-19

The EUA was granted based on data from the phase 3 ACTT-2 trial, which was conducted by the NIAID.

The study, which was fully remote and contactless, aimed to evaluate whether early treatment with fluvoxamine reduced the likelihood of clinical deterioration and disease severity in patients with mild COVID-19 illness.

Investigators evaluated the relationship between atopic dermatitis and frequency of severity markers in patients hospitalized with COVID-19.